Senderra RX Partners, LLC

Senderra RX Partners, LLC, based in the US, specializes in comprehensive specialty pharmacy services, enhancing patient care through advanced technology and streamlined processes for managing specialty medications. Senderra RX Partners, LLC, founded in 2010, is headquartered in Dallas, US. The company focuses on specialty pharmacy services that support medication management for patients and healthcare providers. In December 2025, Nautic Partners agreed to acquire Senderra RX Partners, LLC.

The transaction is subject to customary closing conditions and is expected to be completed in Q1 2026. Senderra Specialty Pharmacy specializes in providing comprehensive specialty pharmacy services designed to streamline the management of specialty medications for patients, prescribers, and pharmaceutical partners. The company emphasizes faster communication and enhanced support through its proprietary technology, SenderraCare+, which offers features such as streamlined onboarding for prescribers and real-time updates on medication shipment statuses for patients. Senderra's core offering includes the fulfillment of specialty medication prescriptions, financial assistance programs, and administrative support to reduce patient stress.

The firm serves a diverse clientele across all 50 states, targeting patients with various medical conditions including asthma, cancer, multiple sclerosis, and rheumatoid arthritis, while also catering to healthcare providers and payers involved in the specialty medication landscape. Senderra Specialty Pharmacy generates revenue through a model that integrates direct-to-consumer services with partnerships in the healthcare ecosystem. The company engages in transactions that involve fulfilling specialty medication prescriptions for patients, which includes providing financial assistance to make medications accessible. Clients include both individual patients as well as healthcare providers who utilize Senderra’s services for their patients' medication needs.

The revenue structure is supported by partnerships with pharmaceutical companies, allowing Senderra to offer enhanced service programs while ensuring compliance with payer requirements. The firm’s operational model is focused on facilitating the delivery of specialty medications and providing additional resources, ensuring that both patients and prescribers receive comprehensive support throughout the medication management process. The company plans to use the funding from December 2025 to support its growth.